Key points are not available for this paper at this time.
Abstract Objectives Internal and external quality assurance materials often use highly processed matrixes. This can render the materials non-commutable. Monitoring laboratory methods with patient medians helps in identifying and correcting systematic errors that may affect diagnostic accuracy. The aim of the present study was to use HbA 1c patient results for monitoring of method performance over time. Methods Test HbA 1c results from 2010 to 2022 was analyzed (n=722,553) regarding changes over time and seasonal variation. The HbA 1c testing was initially performed on a Cobas 501 instrument using immunological detection but in May 2017 the method was replaced by capillary electrophoresis on Capillarys 3 Tera. Results There was a steady decrease in HbA 1c values. From 2011 to 2021 the decrease was for 0.10 percentile 6.6 %, lower quartile 7.9 %, median 10.2 %, mean values 9 %, upper quartile 11.2 %, and 0.90 percentile 9.3 %. No clear shift in HbA 1c levels was observed due to the shift in methods. The median HbA 1c values per month was approximately 44 mmol/mol (6.2 %, DCCT/NGSP). The only month with a median HbA 1c that differed by more than 1 mmol/mol was July with a median value of 42 mmol/mol (6.0 %). Conclusions The patient data showed a similar decrease as in the National Diabetes Register which indicates that the method is stable over time without any sudden changes and that the seasonal variation is low. The continuous decrease in HbA 1c values over time is most likely to a shift towards earlier detection of patient with diabetes and improved treatment.
Rollborn et al. (Tue,) studied this question.